or Try an Advanced Search...

    Technical Analysis for DYN - Dyne Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 28.39 -6.33% -1.92
    DYN closed down 6.33 percent on Friday, November 15, 2024, on 1.33 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical DYN trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Multiple of Ten Bearish Other 0.00%
    Fell Below 20 DMA Bearish -6.33%
    Fell Below 200 DMA Bearish -6.33%
    Fell Below 50 DMA Bearish -6.33%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.33%
    Multiple of Ten Bullish Other -6.33%
    Inside Day Range Contraction -6.33%
    Gapped Down Weakness -6.33%
    Crossed Above 20 DMA Bullish -16.82%
    Older End-of-Day Signals for DYN ...

       Recent Intraday Alerts

    Alert Time
    Down 1 ATR 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Down 5% 2 days ago
    Down 3% 2 days ago
    Down 2 % 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DYN Chart by TradingView
    Basic chart:

    Profile

    Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Oligonucleotide Duchenne Genetic Genealogy Myotonic Dystrophy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases

    Is DYN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Dyne Therapeutics GAAP EPS of -$0.96 misses by $0.25
    Nov 12 Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
    Nov 11 Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases
    Oct 24 Dyne cut to neutral by J.P. Morgan on stock's outperformance
    Oct 22 Looking Into Dyne Therapeutics's Recent Short Interest
    Oct 21 Top small-cap stock picks from Morgan Stanley following the group's upgrade to neutral
    Oct 9 Dyne Therapeutics Presents Data at World Muscle Society Congress Highlighting Promise of FORCE™ Platform to Address Underlying Causes of Neuromuscular Diseases
    Oct 7 Dyne Therapeutics, Inc. (DYN): A Hot Stock to Buy Now
    Sep 23 Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
    Sep 6 CEO, President & Director of Dyne Therapeutics John Cox Buys 640% More Shares
    See more DYN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 47.45
    52 Week Low 10.03
    Average Volume 1,072,746
    200-Day Moving Average 32.20
    50-Day Moving Average 32.48
    20-Day Moving Average 30.21
    10-Day Moving Average 29.53
    Average True Range 2.20
    RSI (14) 42.20
    ADX 29.07
    +DI 24.43
    -DI 20.79
    Chandelier Exit (Long, 3 ATRs) 29.17
    Chandelier Exit (Short, 3 ATRs) 34.26
    Upper Bollinger Bands 33.79
    Lower Bollinger Band 26.62
    Percent B (%b) 0.25
    BandWidth 23.72
    MACD Line -0.99
    MACD Signal Line -1.22
    MACD Histogram 0.2337
    Fundamentals Value
    Market Cap 2.3 Billion
    Num Shares 81.1 Million
    EPS -3.59
    Price-to-Earnings (P/E) Ratio -7.91
    Price-to-Sales 0.00
    Price-to-Book 12.82
    PEG Ratio 0.19
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 32.62
    Resistance 3 (R3) 32.89 31.76 31.92
    Resistance 2 (R2) 31.76 30.68 31.62 31.68
    Resistance 1 (R1) 30.07 30.01 29.51 29.80 31.44
    Pivot Point 28.94 28.94 28.65 28.80 28.94
    Support 1 (S1) 27.25 27.86 26.69 26.98 25.34
    Support 2 (S2) 26.12 27.19 25.98 25.10
    Support 3 (S3) 24.43 26.12 24.87
    Support 4 (S4) 24.16